Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-157
TNBC
Basal B
Selumetinib
MEK
MAPK
12594.155
uM
inf
1.06540
0.7747 0.8100 5.0000 0.0570
0.8924
1.3872
MDA-MB-157
TNBC
Basal B
Sigma A6730
AKT
AKT
12594.165
uM
14.42930
18.00520
-0.9472 -0.9508 4.8113 0.1719
0.9959
1.4798
MDA-MB-157
TNBC
Basal B
Sirolimus
MTOR
MTOR
7495.069
uM
inf
inf
1.0500 1.0500 0.0000 0.0388
0.0179
0.5089
MDA-MB-157
TNBC
Basal B
Sirolimus
MTOR
MTOR
7879.068
uM
inf
42.49340
0.8431 0.8429 4.6142 0.0070
0.7219
1.8348
MDA-MB-157
TNBC
Basal B
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7496.085
uM
inf
inf
0.5054 0.5054 0.0000 0.1591
0.2284
1.0748
MDA-MB-157
TNBC
Basal B
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7498.084
uM
425.10560
948.95960
-0.0440 -1.0000 1.3681 0.1285
0.9443
1.1749
MDA-MB-157
TNBC
Basal B
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7498.067
uM
inf
inf
-0.9434 -0.9434 0.0000 0.3215
0.4385
1.1346
MDA-MB-157
TNBC
Basal B
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7496.067
uM
6.0810
7.5510
-0.9823 -0.9750 4.9967 0.4702
0.9930
1.1301
MDA-MB-157
TNBC
Basal B
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7495.067
uM
4.22520
6.95350
-0.9987 -1.0000 2.2053 0.5144
0.9976
1.1275
MDA-MB-157
TNBC
Basal B
TAPI-0
TACE/Collagenase
7496.096
uM
inf
inf
0.7820 0.7820 0.0000 0.0905
0.4104
1.0771
MDA-MB-157
TNBC
Basal B
Taxol
TUBB
TUBB
10093.002
uM
0.00477
0.00766
-0.8190 -0.7899 2.0005 1.1679
0.9965
0.9296
MDA-MB-157
TNBC
Basal B
TCS 2312
CHK1
CHK
12594.152
uM
0.18047
0.21835
-0.9179 -0.7965 4.9999 0.6900
0.9896
1.3085
MDA-MB-157
TNBC
Basal B
TCS PIM-1 1
Pim kinase
PIM
12594.135
uM
inf
inf
0.8522 0.8522 0.0000 0.0205
0.3273
1.3446
MDA-MB-157
TNBC
Basal B
Temsirolimus
MTOR
MTOR
12594.168
uM
26.46490
39.82910
-0.9566 -1.0000 2.6876 0.2914
0.9332
1.2703
MDA-MB-157
TNBC
Basal B
Topotecan
TOP1
TOP
7879.077
uM
0.48708
0.87470
-0.5235 -0.5063 1.1946 0.5926
0.9862
1.8534
MDA-MB-157
TNBC
Basal B
Torkinib
15321.211
uM
0.03892
0.91831
-0.4972 -0.9420 0.3351 0.6929
0.9944
2.7437
MDA-MB-157
TNBC
Basal B
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
12594.169
uM
4.1810
16.62640
-0.6267 -1.0000 0.7958 0.3446
0.9651
1.4097
MDA-MB-157
TNBC
Basal B
TPCA-1
IKK
NFKB
7496.093
uM
7.4640
4.15410
0.4346 0.4733 4.9999 0.1418
0.9329
0.9777
MDA-MB-157
TNBC
Basal B
Trametinib
MEK
MAPK
10093.012
uM
inf
inf
0.3958 0.3958 0.0000 0.4812
0.3474
1.0064
MDA-MB-157
TNBC
Basal B
Trichostatin A
HDAC
HDAC
7496.065
uM
15.89350
28.96770
-0.9812 -0.9990 1.8291 0.8612
0.9848
0.9526
MDA-MB-157
TNBC
Basal B
Trichostatin A
HDAC
HDAC
7498.065
uM
20.05210
33.62560
-0.9459 -0.9550 2.0662 0.7874
0.9950
1.1827
MDA-MB-157
TNBC
Basal B
Trichostatin A
HDAC
HDAC
7495.065
uM
15.09490
25.91660
-0.9648 -0.9616 1.9846 0.7955
0.9993
1.2645
MDA-MB-157
TNBC
Basal B
Triciribine
AKT
AKT
7496.074
uM
0.25073
0.12334
0.2486 0.2039 0.7383 0.3858
0.8703
1.3504
MDA-MB-157
TNBC
Basal B
Triciribine
AKT
AKT
7495.074
uM
3.20830
73.02160
0.0644 -1.0000 0.3516 0.2590
0.9067
1.1729
MDA-MB-157
TNBC
Basal B
Triciribine
AKT
AKT
7498.074
uM
1.78980
0.19938
0.4151 0.4073 0.7678 0.2286
0.9912
1.0877